Building Indonesia’s Plasma Ecosystem: From Investment to Patient Impact
Jakarta, CNBC Indonesia — Investment in the healthcare sector is not just about building production facilities; it can also strengthen domestic industrial capacity and create opportunities for Indonesia to play a greater role in regional markets. One example is Takeda Life Sciences’ investment, which targets regional markets through the development of a blood plasma ecosystem in Indonesia.
As demand for plasma-derived medicines continues to attract global attention, how can this investment strengthen national health self-sufficiency while delivering tangible benefits for patients? What is Takeda’s strategy for building a sustainable plasma ecosystem, from strengthening the supply chain to potentially making Indonesia a base for reaching regional markets?
More in the following episode of CNBC Indonesia’s Profit programme (Tuesday, 13 October 2026).
Source: jawawa.id (https://jawawa.id/newsitem/building-indonesias-plasma-ecosystem-from-investment-to-patient-impact-1791870636)
Originally published by CNBC Indonesia (https://www.cnbcindonesia.com/lifestyle/20261013111951-35-775666/bangun-ekosistem-plasma-ri-dari-investasi-hingga-dampak-bagi-pasien), translated from Indonesian